Clinical Trials Logo

Clinical Trial Summary

Favorable effects of bariatric surgery have been demonstrated in particular regarding increased insulin sensitivity, decreased blood pressure, improved blood lipids and decreased cardiovascular risk. After surgery, weight loss also leads to improvement of the chronic inflammatory state related to obesity, a strong predictor of the metabolic status. Although obese patients are often affected with type 2 diabetes and hypertension, both related to renal impairment, the existence of a distinct mechanism by which obesity would cause chronic renal insufficiency has been suggested. The mechanisms underlying obesity-related nephropathy have been proposed to involve hyperfiltration, expansion of mesangial cells, hyperperfusion leading to proteinuria and glomerulosclerosis, as noted in obese dogs. In humans, improvements in renal function may be observed following bariatric surgery, although some reported a possibility of increased nephrolithiases. Whether biliopancreatic diversion and gastrectomy alone have similar effects is uncertain. More prospective studies are needed to assess the impact of all types of weight loss surgery to reverse chronic renal insufficiency.

The objective of this study is to document changes in microalbuminuria and metabolic parameters in patients with altered renal function undergoing bariatric surgery. Patients enrolled in the study will show renal function impairment as demonstrated by albumin/creatinine ratio alterations in 2 out of 3 measurements taking place before surgery. We will perform a prospective study of renal function markers (albumin/creatinine ratio) and metabolic parameters (blood lipids, glucose, insulin, inflammatory markers) before and 6, 12, 24 months after surgery in patients with microalbuminuria at study onset (albumin/creatinine ratio 2.0-20.0 mg/mmol in men and 2.8-28.0 mg/mmol in women). Data will be analysed with repeated measures analyses in both subgroup. Thereafter, a linear regression model will be created to adjust for potentially confounding factors such as hypertension and diabetes. We hypothesize that patients with severe obesity and altered renal function, whether they are diabetic or not, have improved microalbuminuria and metabolic parameters following biliopancreatic diversion with sleeve gastrectomy or sleeve gastrectomy alone. The extent of renal function recovery will correlate directly with metabolic improvements.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02068833
Study type Observational
Source Laval University
Contact Marc Lapointe
Phone 4186568711
Email marc.lapointe@criucpq.ulaval.ca
Status Recruiting
Phase N/A
Start date June 2013
Completion date December 2016

See also
  Status Clinical Trial Phase
Recruiting NCT05161572 - Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer Phase 2
Active, not recruiting NCT04422236 - A Post-market, Observational Registry With the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Bariatric Surgery
Completed NCT00827931 - Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery Phase 4
Completed NCT01257711 - A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer N/A
Not yet recruiting NCT06062225 - Protocol for Comparing the Efficacy of Three Reconstruction Methods of the Digestive Tract After Proximal Gastrectomy N/A
Completed NCT00885781 - Efficacy and Safety Comparison Between SMOFlipid and Lipovenoes MCT Phase 4
Not yet recruiting NCT05071755 - Gastrectomy Outcomes in Elderly Patients
Recruiting NCT04798820 - The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING) N/A
Not yet recruiting NCT04191564 - Effect of Anesthetic Conditions on Stapling Thickness and Quality N/A
Recruiting NCT04295473 - Reduced Port Laparoscopic Gastrectomy for Gastric Cancer N/A
Recruiting NCT01142271 - Comparison of Billroth-I and Roux-en-Y Reconstruction After Distal Subtotal Gastrectomy Phase 3
Completed NCT03939819 - Endoscopic vs. Suction Device Calibration in Sleeve Gastrectomy N/A
Recruiting NCT01657812 - A Comparison of Dexmedetomidine and Epidural Anesthesia Under General Anesthesia in Patients Undergoing Gastrectomy Phase 4
Withdrawn NCT00622804 - Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy Phase 3
Recruiting NCT03708783 - Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for AGC N/A
Recruiting NCT06403540 - The Impact of Laparotomy and Analgesia Methods on Diaphragm
Completed NCT03436082 - Post-Market Surveillance With a Novel mHealth Platform
Recruiting NCT06058442 - The Pancreatic Enzymes After Gastrectomy Trial Phase 3
Terminated NCT02836353 - Metabolic Consequences of Gastrointestinal Surgery N/A
Unknown status NCT02503826 - The Efficacy and Optimal Dose of Sufentanil in Patient Controlled Analgesia After Moderate Surgery Phase 4